AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herber, S. C. A.
Right arrow Articles by Manzl, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herber, S. C. A.
Right arrow Articles by Manzl, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Transarterial Chemoembolization in Patients Not Eligible for Liver Transplantation: Single-Center Results

Sascha C. A. Herber1, Gerd Otto2, Jens Schneider1, Markus Schuchmann3, Christoph Düber1, Michael B. Pitton1, Inga Kummer1 and Nicole Manzl1

1 Department of Diagnostic and Interventional Radiology, University of Mainz, Langenbeckstr. 1, 55124 Mainz, Germany.
2 Department of Hepatobiliary Surgery, University of Mainz, Mainz, Germany.
3 I. Medical Clinic, University of Mainz, Mainz, Germany.


Figure 1
View larger version (8K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 Graph shows Kaplan-Meier survival curve for total cohort. Crosses indicate censored data.

 

Figure 2
View larger version (9K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 Graph shows Kaplan-Meier survival curve according to response to transarterial chemoembolization. Survival was significantly better among patients who responded to treatment (p = 0.017). Black line indicates response; gray line, no response; crosses, censored data.

 

Figure 3
View larger version (9K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 Graph shows Kaplan-Meier survival curve comparing initial Okuda scores. Black line indicates Okuda score of I; gray line, Okuda score of II; crosses, censored data (p < 0.0001).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.